<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Whereas many studies have implicated metabolic <z:hpo ids='HP_0001410'>liver dysfunction</z:hpo> as a causative factor for <z:hpo ids='HP_0001513'>obesity</z:hpo>-related type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">Metabolic Syndrome</z:e>, its role as a long-term complication of diabetic metabolism is still mostly unexplored.In contrast to the well-described late diabetic micro- and macro-vascular complications in response to <z:e sem="disease" ids="C0851834" disease_type="Disease or Syndrome" abbrv="">hyperglycemic conditions</z:e> such as nephro- and <z:hpo ids='HP_0000488'>retinopathy</z:hpo> as well as <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, only recent studies have highlighted disturbances of liver function as a novel aspect of diabetic late complications that may substantially impact the overall disease outcome and determine mortality rates in diabetic subjects </plain></SENT>
<SENT sid="1" pm="."><plain>Here we will discuss recent developments in this area, particularly focusing on transcriptional regulators of hepatic dysfunction as a long-term consequence of established <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>